| Safety Study of Chimeric Vaccine to Prevent ETEC Diarrhea (NCT01644565) | U.S. Army Medical Research and Development Command | 2012-08-01 |
| Demonstration of Bioequivalence of Empagliflozin and Metformin Given in One Tablet Compared to the Intake of Single Tablets (NCT01672788) | Boehringer Ingelheim | 2012-08-01 |
| Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer (NCT01473303) | Alliance for Clinical Trials in Oncology | 2012-08-01 |
| Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Filgrastim (G-CSF)Produced by Blausiegel Indústria e Comércio Ltda. Compared to Granulokine Produced by Produtos Roche Químicos e Farmacêuticos S/A. (NCT01549301) | Azidus Brasil | 2012-08-01 |
| Clinical Trial to Investigate the Effect of Proton Pump Inhibitor on the Pharmacokinetics and Pharmacodynamics of Metformin (NCT01857609) | Seoul National University Hospital | 2012-08-01 |
| Enhancing Exposure Therapy for Snake and Spider Phobias (NCT02160470) | University of Texas at Austin | 2012-08-01 |
| Open-Label Study of Bioavailability of E2006 Tablet Versus Capsule Formulations (NCT01673880) | Eisai Inc. | 2012-08-01 |
| A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer (NCT01673737) | Sanofi | 2012-08-01 |
| Safety and Feasibility of Electrochemotherapy in Unresectable Colorectal Adenocarninoma Liver Metastases (NCT02709811) | IGEA | 2012-08-01 |
| Brazilian HIV/Sexually Transmitted Infection (STI) Prevention for Adolescents With Mental Health Disorder (NCT01854853) | New York State Psychiatric Institute | 2012-08-01 |
| A Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer (NCT01522677) | Edward Nelson | 2012-08-01 |
| Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer (NCT01661972) | John Strickler, M.D. | 2012-08-01 |
| Desensitising Celiac Disease Patients With the Human Hookworm (NCT01661933) | The Prince Charles Hospital | 2012-08-01 |
| A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration (NCT01678872) | Oxford BioMedica | 2012-08-01 |
| Adjuvanting Viral Vectored Malaria Vaccines With Matrix M (NCT01669512) | University of Oxford | 2012-08-01 |
| A Study of RO5429083 Alone or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia (NCT01641250) | Hoffmann-La Roche | 2012-08-01 |
| Nucleus Basalis Deep Brain Stimulation for Thinking & Memory Problems in Parkinson's. (NCT01701544) | University College, London | 2012-08-01 |
| Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod (NCT01795313) | James Felker | 2012-08-01 |
| Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations (NCT01680328) | Novo Nordisk A/S | 2012-08-01 |
| A Study of CAT-1004 Biomarkers in Healthy Subjects (NCT01670773) | Catabasis Pharmaceuticals | 2012-08-01 |
| Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers (NCT01668121) | Orion Corporation, Orion Pharma | 2012-08-01 |
| Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy (NCT01682499) | Beth Israel Medical Center | 2012-08-01 |
| Verapamil vs. Sertraline for Vestibular Migraine & Chronic Subjective Dizziness (NCT01669304) | Mayo Clinic | 2012-08-01 |
| A Study of Vaccination With Poly-ICLC and Dendritic Cells in Patients With Pancreatic Adenocarcinoma (NCT01677962) | Medical University of South Carolina | 2012-08-01 |
| Use of Radiographic Contrast to Detect Dental Caries (NCT01523509) | Creighton University | 2012-08-01 |
| A Phase 1 Single Dose Study of E6011 in Japanese Healthy Adult Male Subjects (Study E6011-J081-001) (NCT01731275) | Eisai Co., Ltd. | 2012-08-01 |
| Does GM-CSF Restore Neutrophil Phagocytosis in Critical Illness? (NCT01653665) | Newcastle-upon-Tyne Hospitals NHS Trust | 2012-08-01 |
| Pharmacokinetic and Injection Site Toleration of BIOD-238 and BIOD-250 Compared to Humalog® in Subjects With Type 1 Diabetes (NCT01811849) | Biodel | 2012-08-01 |
| Safety and Efficacy of Nitric Oxide Gel in Promoting Hair Growth in Male Human Subjects With Androgenetic Alopecia (NCT01347957) | China Medical University Hospital | 2012-08-01 |
| Koning Breast Computed Tomography Guided Biopsy (NCT01750320) | Koning Corporation | 2012-08-01 |
| A Study of LY3015014 in Healthy Participants With High Cholesterol (NCT01671085) | Eli Lilly and Company | 2012-08-01 |
| Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung Cancer (NCT01666977) | Amgen | 2012-08-01 |
| Phase 1 ID93 + GLA-SE Vaccine Trial in Healthy Adult Volunteers (NCT01599897) | Access to Advanced Health Institute (AAHI) | 2012-08-01 |
| Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients (NCT02190604) | Novartis Pharmaceuticals | 2012-07-31 |
| A Study of LY3023414 in Participants With Advanced Cancer (NCT01655225) | Eli Lilly and Company | 2012-07-31 |
| Bioequivalence Trial to Prove Equal Blood Concentrations of Two Different Fluconazole Formulations (NCT03929861) | Bayer | 2012-07-31 |
| Clinical Study of WT2725 in Patients With Advanced Malignancies (NCT01621542) | Sumitomo Pharma America, Inc. | 2012-07-31 |
| Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation (NCT01647659) | GlaxoSmithKline | 2012-07-30 |
| Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery (NCT01660971) | National Cancer Institute (NCI) | 2012-07-30 |
| Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma (NCT01657591) | H. Lee Moffitt Cancer Center and Research Institute | 2012-07-27 |
| Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer (NCT01878695) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-07-26 |
| A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (NCT01682616) | AbbVie | 2012-07-25 |
| Tivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors (NCT01654965) | National Cancer Institute (NCI) | 2012-07-24 |
| Phase I Study of GW856553 (Losmapimod) (NCT01648192) | GlaxoSmithKline | 2012-07-24 |
| A Study of LY3006072 in Healthy Participants (NCT01640249) | Eli Lilly and Company | 2012-07-24 |
| Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT01606241) | Mayo Clinic | 2012-07-24 |
| Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer (NCT01607892) | Karyopharm Therapeutics Inc | 2012-07-23 |
| Study of a Dengue Vaccine (V180) in Healthy Adults (V180-001) (NCT01477580) | Merck Sharp & Dohme LLC | 2012-07-23 |
| Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer. (NCT01649271) | Boehringer Ingelheim | 2012-07-23 |
| Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen (NCT01587040) | Sanofi | 2012-07-20 |
| Factors Affecting Methamphetamine and Opiates Drug Testing (NCT01736332) | National Institute on Drug Abuse (NIDA) | 2012-07-19 |
| Safety Study of Mesenchymal Stem Cells and Spinal Fusion (NCT01552707) | Banc de Sang i Teixits | 2012-07-19 |
| Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NCT01647971) | TG Therapeutics, Inc. | 2012-07-19 |
| A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296) (NCT01557504) | Merck Sharp & Dohme LLC | 2012-07-18 |
| A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology (NCT01672775) | Agensys, Inc. | 2012-07-18 |
| Bisphenol A Controlled Exposure Study (NCT01573429) | National Institute of Environmental Health Sciences (NIEHS) | 2012-07-18 |
| Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253) (NCT01614769) | Merck Sharp & Dohme LLC | 2012-07-18 |
| A Study of JNJ-40346527 in Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT01572519) | Janssen Research & Development, LLC | 2012-07-17 |
| A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension (NCT01484431) | Eli Lilly and Company | 2012-07-17 |
| Investigation of Topical SB705498 on Healthy Volunteers (NCT01673529) | GlaxoSmithKline | 2012-07-17 |
| Study to Assess the Safety of Treatment of Articular Cartilage Lesions With CartiLife® (NCT03517046) | Biosolution Co., Ltd. | 2012-07-17 |
| Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma (NCT01400672) | Masonic Cancer Center, University of Minnesota | 2012-07-17 |
| Norovirus Bivalent-Vaccine Efficacy Study (NCT01609257) | Takeda | 2012-07-16 |
| A Single Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Participants With Renal Insufficiency (MK-4618-014) (NCT01628042) | Merck Sharp & Dohme LLC | 2012-07-16 |
| Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies (NCT01471067) | M.D. Anderson Cancer Center | 2012-07-13 |
| Phase 1 Safety Testing of SAR405838 (NCT01636479) | Sanofi | 2012-07-13 |
| Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer (NCT01596751) | Hope Rugo, MD | 2012-07-12 |
| Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma (NCT01583283) | Celgene | 2012-07-12 |
| Bioequivalence Study of Levomerc 500 mg Tablets (NCT05339295) | University of Karachi | 2012-07-11 |
| Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer (NCT01505868) | M.D. Anderson Cancer Center | 2012-07-11 |
| A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (NCT01633970) | Genentech, Inc. | 2012-07-11 |
| Intradermal Injection of Anti-CTLA-4 in Patients With Stage I/II Melanoma (NCT04274816) | A.J.M. van den Eertwegh | 2012-07-10 |
| Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults (NCT01640691) | Adimmune Corporation | 2012-07-10 |
| Study of Vemurafenib, Carboplatin, and Paclitaxel (NCT01636622) | M.D. Anderson Cancer Center | 2012-07-09 |
| EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (NCT01489371) | Gynecologic Oncology Group | 2012-07-09 |
| Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer (NCT01632332) | Mayo Clinic | 2012-07-09 |
| Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent Glioma (NCT01580969) | University of Utah | 2012-07-06 |
| A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma (NCT01677858) | Amgen | 2012-07-04 |
| BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma (NCT01638936) | Biotest Pharmaceuticals Corporation | 2012-07-03 |
| Ustekinumab for Active Sight-Threatening Uveitis (NCT01647152) | National Eye Institute (NEI) | 2012-07-03 |
| Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia (NCT01623167) | National Heart, Lung, and Blood Institute (NHLBI) | 2012-07-02 |
| A Pharmacokinetic And Bioavailability Study of Intravenous Danoprevir in Healthy Volunteers (NCT01654211) | Hoffmann-La Roche | 2012-07-01 |
| The Effect of Palatal Brushing on Denture Stomatitis (NCT01643876) | Université de Montréal | 2012-07-01 |
| Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-933043 in Healthy Subjects (NCT01605994) | Bristol-Myers Squibb | 2012-07-01 |
| Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma (NCT01606345) | H. Lee Moffitt Cancer Center and Research Institute | 2012-07-01 |
| Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors (NCT01640665) | Yale University | 2012-07-01 |
| Effect of Tivantinib on the QTC Interval in Cancer Subjects (NCT01699061) | Daiichi Sankyo | 2012-07-01 |
| Trabeculectomy With Ologen Collagen Implant vs Trabeculectomy With Provisc in Steroid Induced Glaucoma (NCT01912638) | National Centre of Ophthalmology named after academician Zarifa Aliyeva | 2012-07-01 |
| Intranasal Glutathione in Parkinson's Disease (NCT01398748) | Bastyr University | 2012-07-01 |
| EF5 in Melanoma Patients (NCT01752257) | Douglas Tyler | 2012-07-01 |
| Phase 1b Study to Investigate the Safety and Maximum Tolerated Dose of Aldoxorubicin (INNO-206) Plus Doxorubicin HCL in Subjects With Advanced Solid Tumors (NCT01673438) | ImmunityBio, Inc. | 2012-07-01 |
| Effects of Topiramate on Adolescent Alcohol Use: Efficacy and Mechanisms (NCT01641445) | Brown University | 2012-07-01 |
| Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes (NCT01664624) | AstraZeneca | 2012-07-01 |
| Pharmacokinetics of Ceftaroline in Normal and Obese Subjects (NCT01648127) | Keith A. Rodvold | 2012-07-01 |
| Study to Evaluate the Safety and Efficacy of Dermal Injections of JVS-100 Given to Adults Receiving Median Sternotomy (NCT01657045) | SironRX Therapeutics, Inc. | 2012-07-01 |
| Seal-V Safety and Performance Study (NCT01625481) | Sealantis Ltd. | 2012-07-01 |
| Split Wound Comparison of Trichophytic Closure Techniques for Donor Site in Hair Transplantation (NCT01655602) | Siriraj Hospital | 2012-07-01 |
| Study on the Safety and Efficacy of Nitric Oxide Gel in Subjects With Pressure Sore (NCT01351493) | China Medical University Hospital | 2012-07-01 |
| A Phase 1 Study to Assess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tolerability, of Ranolazine (NCT01675973) | Gilead Sciences | 2012-07-01 |
| Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma (NCT01555853) | Washington University School of Medicine | 2012-07-01 |